Turnover: 53.7 billion EUR (2022)

Country: Germany

Description: Of German origin, Bayer opened its first pharmaceuticals department in 1888, 25 years after it was founded. Thirty percent of the Bayer Group's sales come from its healthcare subsidiary, with leading products in the anticoagulant (Xarelto) and anticancer (Stivarga, Xofigo) markets

Bayer has been expanding its presence in the herbal medicine market since the early 2010s, thanks to the acquisition of Steigerwald in 2013. Steigerwald specializes in analgesic, anti-inflammatory and digestive products such as Iberogast. Created in the late 1950s, Iberogast, composed of 9 essential plants, was distributed in 30 countries in 2013, enabling Bayer to invest significantly in the herbal medicine market

The Consumer Health division generated sales of 159.4 million euros in 2019, or 12.1% of total sales. This division covers vitamins and minerals, dermatological care and treatment, gastroenterology, phytotherapy, analgesia and women's intimate health

Bayer's range of herbal medicines focuses on two main products: Euphytosis night and day

News

Chemicals in the midst of a recovery, Bayer considers spin-offs 09/11/2023

  • Bayer sales: Close to 50 billion euros.
  • Date on which Bayer will make a decision on the demerger of its entities: March 2024.
  • Loss of value of the Bayer Group in five years: 40%.
  • Bayer weighed down by falling glyphosate sales

Bayer's glyphosate sales plummet 25/07/2023

  • Full-year sales for the current financial year are forecast at between 48.5 and 49.5 billion euros.
  • Bayer acquired the US group Monsanto in 2018 for over 63 billion euros.
  • Bayer shares have lost half their value since 2018.

Financial Data

DUNS: 562038893

Legal Name: BAYER SAS

Address: 16 RUE JEAN MARIE LECLAIR , 69009 LYON 9EME

Number of employees: 103824 (2020)

Capital: 112 539 893 EUR


Financial Data:

Year Turnover (€) Net Profit (€) Fiscal Year End Fiscal Year Duration
2019 1 311 193 770 EUR 182 088 868 EUR 31/12/2019 12
2018 1 390 573 040 EUR -4 202 198 EUR 31/12/2018 12
2017 1 411 796 358 EUR 193 919 768 EUR 31/12/2017 12
2016 1 535 942 307 EUR 105 784 883 EUR 31/12/2016 12
2015 1 709 505 879 EUR 76 905 988 EUR 31/12/2015 12

Studies mentioning this company

> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)

 

Ask Sector-GPT  

Sector-GPT est la première IA dédiée aux informations sectorielles.